Werber et al. first reported the correlation between DNA methylation and the expression of CTA genes, and found that the CTA gene, MAGE-A1, was activated by treatment of a human melanoma cell line with the DNA demethylating agent, 5-aza-2’-deoxycytidine (5-aza-CdR) [2]. This evidence concerns the gene MAGEA1 and melanoma.